secwatch.observer — SEC 8-K summary
======================================

Issuer:     SELLAS Life Sciences Group, Inc. (SLS)
CIK:        0001390478
Form:       8-K
Filed at:   2025-06-18T23:59:59+00:00
Accession:  0001104659-25-060704
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

SELLAS annual meeting results: directors re-elected, ESPP amendment approved
----------------------------------------------------------------------------

- Re-elected Class III directors Stergiou (36.4M for) and Varian (36.7M for); broker non-votes 17.8M.
- Ratified Baker Tilly as auditor for FY2025: 56.9M for, 3.4M against, 1.0M abstain.
- Approved ESPP amendment increasing shares by 800,000: 28.8M for, 14.0M against.
- Non-binding advisory vote on executive compensation passed: 29.6M for, 12.8M against.
- Recommended annual frequency for future say-on-pay votes (34.8M for 1 year).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1390478/000110465925060704/0001104659-25-060704-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1390478/000110465925060704/tm2518346d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-060704

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer